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Abstract
Although blood vessel growth occurs readily in the systemic bronchial circulation, angiogenesis in the pulmonary
circulation is rare. Compensatory lung growth after pneumonectomy is an experimental model with presumed
alveolar capillary angiogenesis. To investigate the genes participating in murine neoalveolarization, we studied the
expression of angiogenesis genes in lung endothelial cells. After left pneumonectomy, the remaining right lung
was examined on days 3, 6, 14 and 21days after surgery and compared to both no surgery and sham thoracotomy
controls. The lungs were enzymatically digested and CD31
+ endothelial cells were isolated using flow cytometry
cell sorting. The transcriptional profile of the CD31
+ endothelial cells was assessed using quantitative real-time
polymerase chain reaction (PCR) arrays. Focusing on 84 angiogenesis-associated genes, we identified 22 genes with
greater than 4-fold regulation and significantly enhanced transcription (p <.05) within 21 days of pneumonectomy.
Cluster analysis of the 22 genes indicated that changes in gene expression did not occur in a single phase, but in
at least four waves of gene expression: a wave demonstrating decreased gene expression more than 3 days after
pneumonectomy and 3 sequential waves of increased expression on days 6, 14, and 21 after pneumonectomy.
These findings indicate that a network of gene interactions contributes to angiogenesis during compensatory lung
growth.
Introduction
In most circumstances, angiogenesis does not occur in
the adult pulmonary circulation [1,2]. Although struc-
tural adaptations are well-documented in the bronchial
circulation [3,4], the evidence for angiogenesis in the
pulmonary circulation is sparse [5]. Pulmonary angio-
genesis has been demonstrated in a few animal models
including biliary cirrhosis [6], chronic Pseudomonas
infections [7], metastatic disease [8], and post-pneumo-
nectomy lung growth [9]. The finding that experimental
(monocrotaline) pulmonary hypertension induces angio-
genesis in the pleura and bronchovascular bundle, but
not in the alveolar capillaries [3], underscores the dis-
tinctive biology of pulmonary angiogenesis.
Post-pneumonectomy compensatory lung growth is a
particularly intriguing example of pulmonary angiogen-
esis. Within weeks of pneumonectomy, compensatory
lung growth has been documented in many mammalian
species including rats [10], mice [11] and dogs [12].
Recent evidence indicates that lung growth does not
reflect alveolar distension, but an increase in the num-
ber of alveoli [13]. Working in the dog model, Hsia and
colleagues estimated that the remaining lung after right
pneumonectomy increases its capillary blood volume
43% and the capillary surface area 34% [9]. Using a
design-based estimate of capillary length [14] and allo-
metric scaling, a comparable increase in mouse lung
blood volume implies sufficient angiogenesis for more
than 3 km of new pulmonary vessels. The mechanism of
this dramatic pulmonary vascular growth remains
unclear.
Previous work in murine post-pneumonectomy com-
pensatory lung growth has implicated a diverse set of
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mal growth factor (Egr1) [15], keratinocyte growth factor
(Fgf7) [16], hepatocyte growth factor (Hgf )[17], hypoxia-
inducible factor-1a (Hif1a) [18], endothelial nitric oxide
synthase (Nos3) [19], platelet-derived growth factor b
(Pdgfb [20], and vascular endothelial growth factor
(Vegfa) [21]. Attempts to define transcriptional regula-
tion using microarrays and bulk RNA, however, have
identified few genes clearly associated with capillary
angiogenesis [22,23].
The complex morphogenetic changes in the growing
lung include epithelial and stromal growth as well as
pulmonary vascular angiogenesis. This dynamic process
of tissue morphogenesis suggests a coordinated process
involving complex network interactions and intercellular
signaling. In this report, we study a transcriptional sig-
naling of a central component pulmonary angiogenesis;
namely, the pulmonary endothelium.
Methods
Mice
Male C57/B6 mice (Jackson Laboratory, Bar Harbor,
Maine), 25 to 33 gm, were used in all experiments. The
care of the animals was consistent with guidelines of the
American Association for Accreditation of Laboratory
Animal Care (Bethesda, MD); all animal protocols were
reviewed and approved by the Institutional Care and
Use Committee.
Gene expression study design
The age-matched mice received identical care prior to
selection for one of three experimental groups: 1) no
surgery control, 2) sham thoracotomy control, and 3)
left pneumonectomy. Experimental time points were at
D a y0 ,3 ,6 ,1 4a n d2 1d a y s .D a y0s t u d i e dg e n e
expression in the right lung without any prior surgery
(sham thoracotomy or left pneumonectomy)(N = 15
mice). Days 3, 6, 14 and 21 compared the right lung
after left pneumonectomy with no surgery controls (N
≥ 9m i c ee a c ht i m ep o i n t ) .D a y1 4 ,t h ed a yr e f l e c t i n g
expression of the peak number of statistically signifi-
cant genes, compared all three experimental groups
(left pneumonectomy, sham thoracotomy and no sur-
gery controls)(N = 9 mice per condition). In each
experimental group, enzymatic digestion of the right
lung was followed by isolation of the CD31
+CD11b
-
“endothelial cells” by flow cytometry cell sorting. In
some experiments, three parameter (CD31
+CD11b
-
CD45
-) cell sorting was used. For the endothelial ana-
lysis presented, no significant difference between 2 and
3 parameter sorting was identified. RNA was isolated
from the endothelial cells and used for characterizing
angiogenesis-related gene expression.
Pneumonectomy
After anesthesia and intubation, the animal was venti-
lated on a Flexivent (SciReq, Montreal, QC Canada) at
ventilator settings of 200/min, 10 ml/kg, and PEEP of 2
cmH2O with a pressure limited constant flow profile
[24]. A thoracotomy was created in the left fifth inter-
costal space. The hilum was ligated with a 5-0 surgical
silk tie (Ethicon, Somerville, NJ) and the lung sharply
excised. A recruitment maneuver involving a 3 sec ramp
to 30 cmH2O and a 3 sec plateau was performed while
closing the thoracotomy with a 3-0 silk stitch (Ethicon).
At the completion of the procedure, the animal was
removed from the ventilator, maintained on a warming
blanket and observed for spontaneous ventilation. The
FlexiVent (SCIREQ) system was used to determine lung
volumes at a 30 cmH2O inflation pressure [24].
Immunohistochemical staining
Cryostat sections were obtained from lung specimens
perfused with O.C.T. compound and snap frozen. The
slides were serum blocked and treated with anti-Ki-67
(Clone TEC-3, Dako, Hamburg, Germany) monoclonal
antibodies (mAb) at 10-20 ug/m for one hour. After rin-
sing, the anti-Ki-67 binding was detected with an avi-
din-biotin-peroxidase complex (Vectastatin ABC-Kit,
Vector Laboratories) or with the Envision
® kit (Dako)
and counter-stained with hematoxylin.
Lung digestion
The lung was processed in a modification of a proce-
dure previously described [25]. Briefly, the lung was har-
vested at the airway to minimize extra pulmonary
airway. The lung parenchyma was minced into 1 mm
3
pieces and processed by enzymatic digestion: 1 mg/ml
collagenase (Sigma, St. Louis, MO) and 2.5 U/ml dispase
solution (Collaborative Biomedical Products, Bedford
MA). The suspension was incubated at 37°C on a rotary
shaker for 40 min. The lung was triturated using an 18
g needle and filtered through a 70 um nylon mesh
screen (BD Falcon, Bedford, MA) prior washing in
serum containing RPMI-1640 medium (Thermo scienti-
fic, Pittsburgh, PA). Cells were treated with red blood
cell lysis buffer (BD Pharm Lyse, BD Biosciences)
diluted 1:10 in H2O and used at the concentration of 1-
3×1 0
7/ml.
Cell count and calculation
The digested lung cells were counted using a Neubauer
hemacytometer (Fisher, Pittsburgh, PA). Dead cells were
excluded by trypan blue (Sigma, St Louis, MO). The
number of CD31
+ cells was calculated by using flow
cytometric analysis: (CD31
+ c e l ln u m b e r )=( t o t a ll u n g
cell number) × (% of CD31
+ cells among total cells)/100.
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For cell cycle analysis, the digested lung cells were
stained at 1-2 × 106 cells/ml with 10 uM Hoechst
33342 (Invitrogen, Carlsbad, CA). After defining ModFit
parameters (Modfit, Verity Software House, Topsham
ME), the viable lung cells were gated based on forward
and side scatter parameters to exclude debris. In each
experiment, the digested lung cells were stained at 1-2 ×
10
6 cells/ml with 10 uM Hoechst 33342 (Invitrogen,
Carlsbad, CA) in media containing 2% fetal calf serum
at pH7.2 for 60 minutes. The cells were immediately
analyzed using a tri- excitation laser (407 nm, 488 nm
and 633 nm ex) and a FACSCanto II flow cytometer
(BD Biosciences, Franklin Lakes, NJ). The samples were
individually assessed to be within the guidelines of the
DNA Consensus Conference criteria for quality (extra-
polated to non-neoplastic tissue)[26]. After defining
ModFit parameters, the viable lung cells were gated
based on forward and side scatter parameters to exclude
debris.The cells were analyzed by the ModFit autoanaly-
sis and autolinearity algorithms (Verity Software House,
Topsham ME). Because of nuclear density interference
and other staining nonlinearities [27], the G2/G1 ratio
was typically modified using the ModFit autolinearity
algorithm. Autolinearity G2/G1 ratios ranged from 1.93-
1.99. ModFit estimates of aggregates was 4.9 ± 4.0% and
debris was 13.4 ± 5.8% of total events. The mean num-
ber of all cycle events was 74,996 ± 12750 and the mean
number of modeled events was 90,471 ± 10359.
Flow cytometry
For phenotypic analysis, the digested lung cells were
incubated with a 5-fold excess of directly conjugated
fluorescein isothiocynate (FITC) or phycoerythrin (PE)
anti-mouse antibodies with isotype controls: anti-CD31
(rat IgG2a, Clone 390, eBioscience)[28], anti-CD11b (rat
IgG2b, Clone M1/70, BD Bioscience)[29] and anti-CD45
(rat IgG2b, Clone 30-F11, eBioscience)[30] prior to ana-
lysis using a tri-laser flow cytometer (BD FACSAria and
FACSCanto II (BD Biosciences) with tri excitation laser
(407 nm, 488 nm and 633 nm ex). The data were ana-
lyzed by FCS Express 4 software (De Novo Software,
Los Angeles, CA). In all analyses, debris were eliminated
by gating the alive cell population of side and forward
light scatter and further by gating 7AAD (BD Bios-
ciences)-negative population as previously described
[31]. In most experiments, the analysis was based on
100,000 events.
RNA and quantitative PCR
In all RNA isolations, the total RNA quality was
assessed by using an Agilent 2100 Bioanalyzer (Agilent
Technologies, Palo Alto, CA). RNA integrity numbers
(RIN) of the RNA samples were uniformly greater than
7.3 (mean 8.5; range 7.3 to 9.8)[32]. Real-time PCR was
performed with SYBR green qPCR master mixes that
include a chemically-modified hot start Taq DNA poly-
merase (SABiosciences, Frederick, MD). PCR was per-
formed using an ABI Prism 7300 Real-Time PCR
System (Applied Biosystems).
PCR arrays
The commercially available PCR arrays, obtained from
S.A. Biosciences (Frederick, MD), included the Endothe-
lial Cell Biology Array (PAMM-015), Inflammatory
Cytokines and Receptors Array (PAMM-011), Dendritic
& Antigen Presenting Cell Array (PAMM-406) and the
Angiogenesis Array (catalog PAMM-024). Real-time
PCR was performed with SYBR green qPCR master
mixes that include a chemically-modified hot start Taq
DNA polymerase (SABioscience). PCR was performed
on ABI 7300 Real-Time PCR System (Applied Biosys-
tems, Carlsbad, CA). For all reactions, the thermal
cycling conditions were 95°C for 10 min followed by 40
cycles of denaturation at 95°C for 15 sec and simulta-
neous annealing and extension at 60°C for 1 min. The
two sets of triplicate control wells (RTC and PPC) were
also examined for inter-well and intra-plate consistency;
standard deviations of the triplicate wells were uniformly
less than 1Ct. The variance of genes common to the 4
arrays were uniformly less than 0.5Ct.T or e d u c ev a r -
iance and improve inferences per array [33], a design
strategy was used that combined pooled samples (3-4
mice per array).
Statistics and bioinformatics
Our quantitative PCR assumed that DNA template and/
or sampling errors were the same for all amplifications;
our internal control replicates indicated that our sample
size was sufficiently large that sampling errors were sta-
tistically negligible [34]. The exponential phase of the
reaction was determined by a statistical threshold (10
standard deviations). Flow cytometry statistical analysis
was based on measurements in at least three different
mice. The unpaired Student’st - t e s tf o rs a m p l e so f
unequal variances was used to calculate statistical signif-
icance. The data was expressed as mean ± one standard
deviation. The significance level for the sample distribu-
tion was defined as P <.05. Clustering of the statistically
significant genes (t-test; p <.05) was performed using an
agglomerative hierarchical clustering algorithm [35,36].
Results
Post-pneumonectomy lung growth
To confirm a compensatory increase in lung volume
after pulmonary resection, we studied the pulmonary
mechanics of mice on Days 3, 6, 14, and 21 after left
pneumonectomy. Using the FlexiVent rodent ventilator,
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(referred to as the “TLC” volume by SciReq) demon-
strated a statistically significant increase in lung volumes
within 2 weeks of surgery (Figure 1A; p <.01). During
the phase of greatest change in volume, immunohisto-
chemistry of the lung using antibodies against the Ki-67
cell cycle protein demonstrated staining in the alveolar
septa (Figure 1C). Nuclei positive for the Ki-67 protein
were evident in both the alveolar septa and juxta-alveo-
lar interstitium likely reflecting cell cycle activity in
many lung cell types.
Endothelial cells after pneumonectomy
A quantitative assessment of the time course of cell pro-
liferation was obtained using cell cycle flow cytometry of
CD31
+ endothelial cells (Figure 2). An early increase in
S-phase cells was noted on Day 3 after pneumonectomy.
By Day 6 after pneumonectomy, 10% of the cells in the
right lung were in either the S or G2 phases of the cell
cycle. To investigate the endothelial response to pneu-
monectomy, the lung digests were analyzed by flow
cytometry. Baseline analysis by flow cytometry demon-
strated 8-15% of the cells were positive for the endothe-
lial cell surface molecule CD31 (PECAM-1) and
negative for leukocyte markers CD11b and CD45 (Fig-
ure 3A-D). As expected, the endothelial cells uniformly
expressed the surface molecules VEGFR1 (Flt1)a n d
CD31(Pecam1) (Figure 3E-F).
To confirm the cells isolated by flow cytometry were
endothelial cells, the transcriptional profile was assessed
by PCR arrays. Of note, the isolated RNA was consis-
tently negative for leukocyte genes (Figure 4A), but posi-
tive for genes associated with endothelial cell function-
associated molecules, extracellular matrix molecules and
angiogenesis and growth factor molecules (Figure 4B-D).
Angiogenesis-related transcription
To investigate the endothelial response to pneumonect-
omy, the transcriptional profile of the CD31
+ cells on
Days 3, 6, 14 and 21 after pneumonectomy was studied
by PCR arrays. Volcano plots were used to identify gene
transcription significantly increased or decreased relative
to age-matched or sham thoracotomy control mice. At
3 days after pneumonectomy, no genes were signifi-
cantly different from control (p <.05) with expression
levels >4-fold controls; however, analyses 6 days after
pneumonectomy identified 14 genes with differentially
increased transcription (Figure 5B). Similarly, 17 genes
demonstrated enhanced transcription 14 days after
pneumonectomy (Figure 5C). In contrast, the RNA
obtained from CD31
+ cells 21 days after pneumonect-
omy demonstrated only 3 genes with increased expres-
sion (Figure 5D). Expression of 9 genes was increased at
t w oo rm o r et i m ep o i n t s( Col18a1, Col4a3, Csf3, Ereg,
F2, Il6, Lect1, Sphk1, and Vegfa). None of the genes with
decreased expression after pneumonectomy reached sta-
tistical significance with a >4-fold change. Of note, there
was no significant difference in gene expression when
sham thoracotomy and the no surgery controls were
compared 14 days after pneumonectomy (Figure 5E).
Similarly, the CD11b
- CD31
- cells used for comparison
in the gene expression analysis demonstrated temporal
stability; there was little change in angiogenesis gene
expression when the Day 0 and Day 14 post-pneumo-
nectomy arrays were compared (Figure 5F).
Temporal expression pattern
The temporal patterning of the 84 genes in the angio-
genesis PCR array was investigated using hierarchical
clustering. Because of the wide variation in quantitative
gene expression, we used pairwise Pearson correlation
coefficients to assess similarity/dissimilarity. The genes
Figure 1 Functional and histologic evidence of compensatory
lung growth after pneumonectomy (Day 0). A) Lung volumes
obtained by a FlexiVent maximal vital capacity maneuver (named
TLC by SCIREQ). The mouse was allowed to exhale to residual
volume then ventilated with a 3 sec ramp to a 3 sec plateau at 30
cmH2O pressure. The measured volume was expressed as a percent
of Day 0 post-pneumonectomy baseline. Each data point reflects
the mean of N = 3 mice ± 1 SD; 3 TLC maneuvers per mouse. B)
Control and C) Ki-67 (Clone TEC-3, Dako, Hamburg, Germany)
immunohistochemistry of the lung during the “growth” phase (Day
6) demonstrated scattered positive cells providing evidence of
proliferation within the alveolar septa (arrow, bar = 25 um).
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both a >4-fold change and a statistically significant (p
<.05) difference from control mice (Figure 6). Using this
approach, gene expression clusters demonstrated unex-
pected similarities in genes such as Anpep and Thbs2,a s
well as functionally more predictable similarities in
genes such as Ephb4 and Vegfa. Consistent with phases
or “waves” of gene expression [37], distinct patterns
were identified on Days 3, 6, 14 and 21. Most genes
demonstrated a single wave of expression; only Csf3
demonstrated a bimodal pattern with expression peaks
on Days 6 and 21.
Discussion
In this report, we studied the expression of angiogenesis
genes in isolated endothelial cells during murine post-
pneumonectomy lung growth. The quantitative profiling
of 84 angiogenesis-associated genes suggested several
conclusions. First, pneumonectomy resulted in a sus-
tained transcriptional response in the lung endothelial
cells. The persistent change in the expression of multi-
ple angiogenesis-associated genes suggested a transcrip-
tional “state” that persisted substantially longer than the
7-14 day growth period. Second, the statistically signifi-
cant change in the expression of 22 angiogenesis-
associated genes indicated that alveolar capillary angio-
genesis did not depend upon a single dominant or con-
trolling genetic element, but a complex sequence of
gene expression. An understanding of these temporal
dynamics will likely be necessary for effective therapeu-
tic control. Finally, the use of an isolated cell population
provided transcriptional evidence of intercellular signal-
ing. The expression of genes known to participate in
receptor-ligand pairs suggested testable predictions in
complementary cell types.
A contribution of this study is the “tissue-scale”
approach to post-pneumonectomy alveolar construction.
Tissue-scale models typically consider individual cell
types as “nodes” and the exchanges between cells as
“edges” in computational networks. The structural com-
position of the lung–repeating functional units and rela-
tively uniform cell types–m a k e st h i sa p p r o a c h
particularly appealing in the study of compensatory
growth. In tissue-scale networks, any measurable or
quantifiable property can be considered a variable of
interest to be associated with a node. In adult morpho-
genesis, issues such as cell shape properties and the
mechanical milieu are also among the variables asso-
ciated with a node at this scale. Here, we studied a phe-
notypically uniform cell type (endothelial cells) and
Figure 2 Cell cycle profiling of post-pneumonectomy lung CD31
+ endothelial cells obtained by enzymatic digestion and analyzed
using flow cytometry (ModFit, Verity Software House). Automated analysis of the ModFit model components, processed by a Marquardt
nonlinear least-squares analysis, excluded aggregates (green) and identified S phase (blue hatched area) and G2 phase (second red peak) cells at
five time points (Day 0, 3, 6, 14 and 21). The combined analysis of the percentage of cells in S+G2 phase of the cell cycle at various time points
after pneumonectomy in the column chart (right; mean ± SD; 4-6 mice per time point).
Lin et al. Respiratory Research 2011, 12:98
http://respiratory-research.com/content/12/1/98
Page 5 of 11analyzed the transcriptional profile associated with the
morphogenetic process of angiogenesis. We anticipate
that the value of this data will grow as 1) other nodes in
the tissue-scale network are defined, and 2) more
endothelial cell variables are characterized.
Our data indicate that compensatory growth was not
associated with a single transcriptional wave, but a tem-
poral pattern of gene expression. The concept of a tem-
poral dynamics of gene expression has been explored in
many developmental studies [38,39]. In most cases, the
patterns of gene expression are presumed to reflect a
largely context-insensitive linear cascade of genes with
sequentially ordered expression [40]. An alternative
interpretation is that the temporal dynamics reflect net-
work interactions with intercellular signaling and feed-
back control. For example, the enhanced expression of
Ereg (epigregulin) in endothelial cells suggests a comple-
mentary target receptor on epithelial cells. Ereg is a
member of the epidermal growth factor family and can
function as a ligand of EGFR (epidermal growth factor
receptor), as well as a ligand of most members of the
ERBB (v-erb-b2 oncogene homolog) family of tyrosine-
kinase receptors. Since EGFR is expressed on all epithe-
lial and stromal cells [41], the transcription of Ereg by
Figure 3 Phenotype of lung endothelial cells after enzymatic digestion. A) Flow cytometry light scatter characteristics of the digested lung
cells. Gate 1 was used for subsequent dual parameter analyses. The green population in panels A-D reflect Gate 2 defined in panel B. B) Dual
parameter histogram of lung cells stained with directly conjugated anti-CD31 (390, FITC) and anti-CD11b (M1/70, PE) monoclonal antibodies. C)
Consistent with an endothelial phenotype, the CD31
+/CD11b
- cells in Gate 2 were also negative for the leukocyte antigen CD45 (30-F11, PE). D)
Isotype control of the anti-CD31 antibody. E-F) Surface expression of the Flt1 (VEGFR1) and Pecam1 (CD31) gene products of the endothelial cell
population presented as a single parameter histogram. Gray reflects the surface staining of the isotype control of each antibody; MFI = mean
fluorescence intensity. The CD31
+ cells (Gate 2) were defined as endothelial cells for subsequent experiments.
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tion between these cell types. Perhaps relevant to the
post-pneumonectomy milieu, Ereg has been implicated
in smooth muscle proliferation and differentiation [41],
mechanical strain [42] and wound healing [43]. We pre-
dict that future studies of isolated epithelial cells will
demonstrate the coexpression of complementary recep-
tor-ligand gene pairs.
The number of identifiable waves of gene expression
was a consequence of our experimental design: we stu-
died lungs 3, 6, 14 and 21 days after pneumonectomy.
The time points were chosen to reflect the tempo of
angiogenesis in the developing rat lung. Burri et al. have
described several phases of postnatal lung growth within
21 days: expansion of the lung, rapid alveolarization,
and septal restructuring [44,45]. To provide an overview
of the entire growth period, we have defined the tran-
scriptional pattern over this 21 day period. An alterna-
tive time course is suggested by morphometric studies
[13]. In these investigations, the authors demonstrated a
significant increase in alveolar number by 6 days after
pneumonectomy. A goal of future studies will be to con-
centrate on the earlier phase of endothelial cell tran-
scription (0-6 days) and enhance the resolution of the
pattern described here.
Our findings have several practical limitations. Fore-
most, we used quantitative PCR arrays to identify statis-
tical significance (t-test)w i t h i na n db e t w e e nt i m e
points, but de-emphasized the fold regulation of gene
expression. Contemporary qRT-PCR arrays provide a
quantitative assessment of gene expression relative to
housekeeping genes (ΔCt) and control or calibrator sam-
ples (ΔΔCt) [46]. Although this method obviates the
need for producing a standard curve for each gene, “fold
regulation” can be misleading. For example, the kinase
insert domain receptor Kdr encodes the VEGFR2 recep-
tor and functions as an important mediator of VEGF-
induced endothelial proliferation [47]. Post-pneumonect-
omy Kdr expression was only 2-3-fold higher than non-
pneumonectomy controls, but 80-fold higher in
endothelial cells than in the CD31
-CD11b
- (primarily
epithelial cells) controls. Thus, the biological implica-
tions of a 2-fold change in a highly transcribed gene are
likely to be substantially different from a 2-fold change
i nag e n ew i t hl i t t l eo rn ob a s e l i n et r a n s c r i p t i o n .
Because of the limitations of “fold regulation,” we
emphasized the patterns of expression rather than abso-
lute levels of expression. We used temporal co-expres-
sion as a tool for identifying functional relationships.
Although our temporal clustering analysis was based on
Figure 4 Representative gene transcription profile of CD31
+ cells. Baseline (control) lungs were enzymatically digested and the CD31
+ cells
isolated by flow cytometry cell sorting. The RNA extracted from CD31
+ cells consistently demonstrated RIN greater than 8 (inset: representative
RNA electropherogram). The CD31
+ cells were compared to CD31
-/CD11b
- cells on multiple PCR arrays (PAMM-015, PAMM-011 and PAMM-406,
SABiosciences). The CD31
+ cell gene transcription profile, expressed as the fold regulation (Log2), was grouped by phenotypic and functional
associations: A) leukocyte membrane molecules, B) endothelial cell function-associated molecules, C) extracellular matrix molecules and D)
angiogenesis and growth factor molecules. Data representative of N = 16 mice.
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over time can lead to more sophisticated approaches,
such as time-lagged correlations, to infer functional rela-
tionships [48].
Flow cytometry, an instrument that uniquely analyzes
samples on a per cell basis, provided several advantages
in our study. First, flow cytometry permitted the isola-
tion of a large population of phenotypically uniform
endothelial cells; that is, cells central to both the func-
tional regulation and structural development of new
blood vessels. Second, simultaneous analysis and sorting
by flow cytometry provided a link between molecular
expression and gene transcription [36]. In this report,
we limited our analysis to Pecam1 and Flt1 gene pro-
ducts–namely, the CD31 and VEGFR1 membrane mole-
cules–but a similar approach is applicable to many of
Figure 5 Expression of angiogenesis-related genes in CD31
+ cells after pneumonectomy. A-D) Gene expression in mice 3, 6, 14 and 21
days after pneumonectomy was compared to age-matched controls without surgery. The log2 fold-change in gene expression was plotted
against the p-value (t-test) to produce a “volcano plot.” The vertical threshold reflected the relative statistical significance (red horizontal line,
-log10, p < 0.05); the horizontal threshold reflected the relative fold-change in gene expression (blue vertical line, 4-fold). The significantly up-
regulated expression of specific genes (red elipses): a) Tnfaip2, Plg, Anpep, Pgf, Vegfb and Thbs2;b )Csf3, Col4a3, Sphk1, Ereg, Vegfa, Lect1, Col18a1
and Il6;c )Ereg, Ephb4 and Vegfa;d )Tbx1, Cxcl5, Col4a3, Col18a1, F2, Vegfc, Sphk1, Ccl11, S1pr1, F2, Il6, Lect1, Flt1 and Csf3.e )Sphk1 and Vegfa;f )
Csf3. Each data point reflects triplicate or quadruplicate arrays of 9 to 21 mice (Day 0, N = 15 mice; Day 3, N = 9 mice; Day 6 = 9 mice; Day 14,
N = 9 mice; Day 21, N = 21 mice). E) Indicating a limited impact of the thoracotomy alone, the volcano plot comparison of sham thoracotomy
and no surgery control demonstrated no significant change in gene expression on Day 14 after pneumonectomy. F) Scattergram indicating the
stability of the control cell population (CD11b
- CD31
- ) used for gene expression analysis. Angiogenesis gene expression in the CD11b
-CD31
- cells
was compared on Day 0 and Day 14 after pneumonectomy (N = 3 mice, each time point). Gene expression demonstrated only one gene (Bai1)
with significantly decreased expression on Day 14 after pneumonectomy.
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cell membrane defines a basic regulatory unit of the
genome, sorting endothelial cells approximated a uni-
form transcriptional network [49]. Sorting a population
of endothelial cells, rather than using bulk tissue, is ana-
logous to studying the relatively uniform cell popula-
tions that have facilitated insights into transcriptional
programs in bacteria [50].
The dominant wave of gene transcription occurred on
Day 6 after pneumonectomy. Angiogenesis genes such
as Ereg, Lect1, Plg,a n dCsf3 demonstrated a significant
increase in expression on Day 6 (6- to 30-fold). Interest-
ingly, Vegfa expression continued to rise slightly until
Day 14–resulting in a slightly misleading temporal clus-
tergram. Vegfa has been previously associated with pul-
monary capillary development; the selective inactivation
of the Vegfa gene results in almost complete absence of
pulmonary capillaries [51]. The increased expression of
Vegfa in endothelial cells, however, suggested the possi-
bility of an autocrine effect of Vegfa [52] or a trophic
influence on other components of the regenerating
alveolus. VEGF effects on alveolar type II cells include
the activation of cell proliferation, the stimulation of
surfactant production [53] and the inhibition of apopto-
sis [54]. VEGFR1, a membrane receptor stimulated by
both VEGFA and VEGFB, has been implicated in the
positive regulation of monocyte and macrophage migra-
tion [55].
Finally, expression of genes associated with the regula-
tion of angiogenesis also occurred on Days 6 and 14
after pneumonectomy. Angiogenesis genes such as
Col18a, Col4a3 and Plg are known to participate in
angiogenesis, but are also the precursors to angiogenesis
inhibitors [56]. For example, endostatin is the proteoly-
tic cleavage protein of collagen XVIII and angiostatin is
derived from plasminogen [57]. Similarly, the C-terminal
cleavage products of collagen IV a1, a2a n da3p o s s e s s
anti-angiogenic activities; the most notable example is
the fragment of the a3 chain of type IV collagen
referred to as tumstatin [58]. The varied expression of
these genes indicates that post-pneumonectomy angio-
genesis involves an interactive and interdependent
Figure 6 Temporal expression clustergram mapping of angiogenesis genes. Genes demonstrating a statistically significant increase in
expression (p <.05, t-test) at one or more time points were clustered using an agglomerative hierarchical clustering algorithm. The similarity/
dissimilarity metric, based on the Pearson correlation coefficient between two dimension profiles of qRT-PCR gene expression, identified 4 waves
(i-iv) of gene expression. The dendrogram was based on average linkage clustering. The colored matrix display was encoded based on the value
of the gene at the 5 time points; the relative dissimilarity index in the unshaded portion of the dendrogram was compressed for presentation
purposes.
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Page 9 of 11network of both positive and negative signals; a process
likely involving feedback control.
In summary, we have used a “tissue-scale” approach to
investigate endothelial cell participation in post-pneu-
monectomy lung growth. By using flow cytometry to
isolate CD31
+ endothelial cells and PCR arrays to quan-
tify gene expression, we have 1) contributed gene
expression data to the endothelial cell “node” in tissue-
scale growth networks, and 2) provided insights into the
process of alveolar angiogenesis. Analysis of gene
expression in the endothelial cell “node” did not demon-
strate a single regenerative signal but a temporal pattern
of gene expression. The known physiologic functions of
the expressed genes suggest that gene expression does
not reflect a pre-programmed response, but a highly
interactive and interdependent signaling network. To
test our predictions, future work will define other cell
types ("nodes”) and the exchanges between cells
("edges”) for subsequent analysis in computational net-
works of post-pneumonectomy lung growth.
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